Vanderbilt Center for Antibody Therapeutics (VCAT) Archive — Page 12 of 13

Close-up of a female Aedes aegypti mosquito feeding on human skin, with its abdomen distended and visibly red from ingested blood.
April 7, 2014

Vanderbilt Vaccine Center joins global task force to address urgent viral threat

By John Howser
syringe
March 6, 2014

Multi-center effort targets lethal Ebola, Marburg viruses

Vanderbilt University researchers are collaborating in a multi-center, federally-funded project to develop ways to treat and prevent the highly lethal Ebola and Marburg virus infections.

By Bill Snyder
Close-up of multiple hypodermic syringes arranged diagonally, with transparent barrels, black measurement markings, teal needle hubs, and a red strip crossing the image.
February 5, 2014

Discovery may pave way for RSV vaccine

Vanderbilt University scientists have contributed to a major finding, reported this week in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.

By Bill Snyder
Group portrait of university faculty and administrators standing together at an indoor event, with palm plants and a dark stage backdrop behind them.
January 24, 2014

Nine faculty honored with endowed chairs

Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center.

By Bill Snyder
December 19, 2013

Year in review 2013: A year of achievements, transition for VUMC

By Doug Campbell
Two researchers pose in a laboratory, with shelves of supplies and a computer workstation behind them. The man sits in front wearing a striped shirt, while the woman stands beside him in a patterned dress.
September 5, 2013

Controversial info release aids VUMC bird flu research

Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin.

By Vanderbilt Health News